Evolent Health, Inc. EVH
| Analyst |
Entreprise |
Price during analysis |
Target price |
Potential gain |
Publication date |
| Kevin Caliendo |
UBS |
9.97 $ |
14 $ |
4.03 % |
16/01/2025 |
| Jailendra Singh |
Truist Financial |
9.97 $ |
20 $ |
10.03 % |
15/01/2025 |
| Sean Dodge |
RBC Capital |
11.96 $ |
17 $ |
5.04 % |
14/01/2025 |
| Constantine Davides |
JMP Securities |
12.54 $ |
18 $ |
5.46 % |
10/01/2025 |
| Mohan Naidu |
Oppenheimer |
12.59 $ |
28 $ |
15.41 % |
18/11/2024 |
| Jeff Garro |
Stephens |
24.955 $ |
38 $ |
13.05 % |
17/10/2024 |
| Jailendra Singh |
Truist Financial |
20.87 $ |
33 $ |
12.13 % |
09/08/2024 |
| Sean Dodge |
RBC Capital |
22.04 $ |
42 $ |
19.96 % |
05/06/2024 |
| Jailendra Singh |
Truist Financial |
23.75 $ |
28 $ |
4.25 % |
14/05/2024 |
| Jessica Tassan |
Piper Sandler |
29.6 $ |
51 $ |
21.40 % |
17/04/2024 |
| Richard Close |
Canaccord Genuity |
32.73 $ |
44 $ |
11.27 % |
28/03/2024 |